Terms: = Thyroid cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Treatment
15 results:
1. Adjuvant chemotherapy and survival in males aged 70 years or older with breast cancer: a population-based retrospective study.
Yu Y; Huang K; Liu Y; Chen R; Yu X; Song C
BMC Geriatr; 2024 Mar; 24(1):282. PubMed ID: 38528444
[TBL] [Abstract] [Full Text] [Related]
2. Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study.
Kim DW; Chul Cho B; Pachipala K; Kim SW; Wang CL; Chang GC; Ahn MJ; Alvarez R; Chiu CH; Trigo J; Estival A; Karam SD; O'Brien C; Gowda H; Jiang H; Bauman JE
Lung Cancer; 2024 Apr; 190():107530. PubMed ID: 38471416
[TBL] [Abstract] [Full Text] [Related]
3. Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON).
Garon EB; Cho BC; Luft A; Alatorre-Alexander J; Geater SL; Kim SW; Ursol G; Hussein M; Lim FL; Yang CT; Araujo LH; Saito H; Reinmuth N; Medic N; Mann H; Shi X; Peters S; Mok T; Johnson M
Lung Cancer; 2023 Dec; 186():107422. PubMed ID: 37992595
[TBL] [Abstract] [Full Text] [Related]
4. Preoperative comprehensive malignancy risk estimation for thyroid nodules: Development and verification of a network-based prediction model.
Shao G; Sun B; Shi M; Song Y; Sun Z; Hao X; Li L; Fu Z
Eur J Surg Oncol; 2022 Jun; 48(6):1264-1271. PubMed ID: 35367109
[TBL] [Abstract] [Full Text] [Related]
5. Analysis of correlation factors influencing the outcome of initial 131I remnant ablative therapy in intermediate- to high-risk patients with papillary thyroid microcarcinoma.
Wu R; Liu W; Li N; Wang X; Sun D; Ji Y; Jia Q; Tan J; Zheng W
Nucl Med Commun; 2022 Jun; 43(6):669-674. PubMed ID: 35351838
[TBL] [Abstract] [Full Text] [Related]
6. Could Urinary Iodine Be an Effective Predictive Factor for thyroid cancer After High Dose Radioactive Iodine Therapy?
Cao J; Yun C; Zhu X; Sun Y; Li X; Zhang W
Endocr Pract; 2022 Jun; 28(6):586-592. PubMed ID: 35304327
[TBL] [Abstract] [Full Text] [Related]
7. Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors and Sudden Cardiac Arrest and Ventricular Arrhythmia: Population-Based Cohort Studies.
Dawwas GK; Hennessy S; Brensinger CM; Deo R; Bilker WB; Soprano SE; Dhopeshwarkar N; Flory JH; Bloomgarden ZT; Aquilante CL; Kimmel SE; Leonard CE
Clin Pharmacol Ther; 2022 Jan; 111(1):227-242. PubMed ID: 34331322
[TBL] [Abstract] [Full Text] [Related]
8. Integrative analysis of key candidate genes and signaling pathways in autoimmune thyroid dysfunction related to anti-CTLA-4 therapy by bioinformatics.
Zhang Y; Garofano F; Wu X; Schmid M; Krawitz P; Essler M; Schmidt-Wolf IGH
Invest New Drugs; 2020 Dec; 38(6):1717-1729. PubMed ID: 32500465
[TBL] [Abstract] [Full Text] [Related]
9. Is biopsy enough for papillary thyroid microcarcinoma?: An analysis of the SEER database 2004 to 2013 with propensity score matching.
Liu Z; Zhao Q; Liu C; Zeng W; Ming J; Chen C; Wang S; Xiong Y; Zhang C; Chen T; Huang T; Guo L
Medicine (Baltimore); 2018 Aug; 97(31):e11791. PubMed ID: 30075609
[TBL] [Abstract] [Full Text] [Related]
10. Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis.
Wang C; Zhang X; Li H; Li X; Lin Y
PLoS One; 2017; 12(7):e0179664. PubMed ID: 28704384
[TBL] [Abstract] [Full Text] [Related]
11. 4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomas.
Varinelli L; Caccia D; Volpi CC; Caccia C; De Bortoli M; Taverna E; Gualeni AV; Leoni V; Gloghini A; Manenti G; Bongarzone I
Endocr Relat Cancer; 2015 Oct; 22(5):759-75. PubMed ID: 26206776
[TBL] [Abstract] [Full Text] [Related]
12. cd74 expression and its therapeutic potential in thyroid carcinoma.
Cheng SP; Liu CL; Chen MJ; Chien MN; Leung CH; Lin CH; Hsu YC; Lee JJ
Endocr Relat Cancer; 2015 Apr; 22(2):179-90. PubMed ID: 25600560
[TBL] [Abstract] [Full Text] [Related]
13. Immunohistochemical expression of RBP2 and LSD1 in papillary thyroid carcinoma.
Kong L; Zhang G; Wang X; Zhou J; Hou S; Cui W
Rom J Morphol Embryol; 2013; 54(3):499-503. PubMed ID: 24068396
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of cytologically benign solitary thyroid nodules by ultrasonography: a retrospective analysis of 1877 cases.
Kihara M; Hirokawa M; Masuoka H; Yabuta T; Shindo H; Higashiyama T; Fukushima M; Yamada O; Takamura Y; Ito Y; Kobayashi K; Miya A; Miyauchi A
Auris Nasus Larynx; 2013 Jun; 40(3):308-11. PubMed ID: 23103151
[TBL] [Abstract] [Full Text] [Related]
15. Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis.
Eustatia-Rutten CF; Smit JW; Romijn JA; van der Kleij-Corssmit EP; Pereira AM; Stokkel MP; Kievit J
Clin Endocrinol (Oxf); 2004 Jul; 61(1):61-74. PubMed ID: 15212646
[TBL] [Abstract] [Full Text] [Related]
